Company / R&D Expense
Avalon GloboCare Corp. R&D Expense History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
-
FY2024
5-year range
$0 / $883.9K
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $731,328 to $0 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Avalon GloboCare Corp.'s r&d expense has declined for 4 consecutive years.
- In FY2024, r&d expense decreased 100.0% year-over-year.
- Peak r&d expense was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.96 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $109.6K | -85.0% |
| FY2022 | $731.3K | -17.3% |
| FY2021 | $883.9K | -50.4% |
| FY2020 | $1.8M | +4461.8% |
| FY2019 | $39.1K | +0.0% |
| FY2018 | $39.1K | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026